Leerink Partners: IPOs as lead manager
3 United States IPOs where Leerink Partners is named a lead manager in the offer document, newest first.
Listed
3Shares now trade on the exchange.| IPO | Listed on | Issue price | Issue size |
|---|---|---|---|
| Latigo Biotherapeutics | — | $18 | $345.6M |
| BlossomHill Therapeutics | — | $16 | $150M |
| Attovia Therapeutics | — | $17 | $289M |